Open AccessS304: SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT‐REPORTED OUTCOMES IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2 YEAR FOLLOW‐UP FROM THE CARDINAL STUDY
Author(s) -
Röth A.,
Broome C. M.,
Barcellini W.,
Henrik Anderson Tvedt T.,
Miyakawa Y.,
D'Sa S.,
Cella D.,
Joly F.,
Wang J.,
Sourdille T.,
Shafer F.,
Wardęcki M.,
Weitz I. C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844108.70297.06
Subject(s) - medicine , quality of life (healthcare) , autoimmune hemolytic anemia , anemia , clinical endpoint , physical therapy , clinical trial , nursing